Strategic funding Leverage AgelessRx’s milestone award and $1M fundraising momentum from the XPRIZE Healthspan recognition to offer premium collateral, research partnerships, and expanded clinical trial capabilities to pharma, biotech, and health systems seeking aging-focused outcomes.

Security and trust Address the reported data security incident by offering robust HIPAA-compliant telehealth security assessments, incident response services, and ongoing patient data protection solutions to reinforce confidence for current and prospective enterprise clients.

Scale-ready platform Position AgelessRx as a combined clinician-guided treatment and continuous support model with ongoing longevity research; explore enterprise collaborations with health plans, large employer groups, and wellness programs seeking preventive, evidence-based aging interventions.

Clinical trial access Capitalize on existing clinical trial infrastructure and research sponsorship by offering sponsored studies or data-sharing collaborations to biopharma and contract research organizations aiming to accelerate longevity therapies and real-world evidence generation.

Global growth push With a mid-sized team and substantial revenue, target partnerships with telehealth platforms, wellness networks, and digital health ecosystems that can cross-sell AgelessRx’s longevity care model to broader patient populations and corporate wellness customers.